A dendritic cell vaccine administered before and after autologous stem cell transplant (ASCT) was safe and immunogenic and was associated with durable clinical responses in patients with high-risk multiple myeloma, according ...
Sep 22, 2023
0
51
As the the COVID-19 vaccination campaign continues worldwide, research is ongoing to improve the vaccines available and develop new, effective, and innovative candidates to fight the pandemic and its variants and protect ...
Sep 1, 2021
0
8
The current COVID-19 vaccination campaign involves injecting the vaccine into muscle tissue, but injecting a smaller amount of vaccine in the skin might also provide good protection. The #wakeuptocorona crowdfunding campaign ...
Apr 14, 2021
0
2
With the U.S. facing vaccination delays because of worker shortages and distribution problems, federal health officials now say it's OK to push back the second dose of the two-part vaccine by as much as six weeks.
Jan 28, 2021
0
11
To confront the many challenges that infectious diseases pose to mankind head-on, a multi-disciplinary team of bioengineers, materials-scientists and immunologists at Harvard's Wyss Institute has developed a broadly deployable ...
Aug 20, 2020
0
8
Treatment with a HER2-targeted therapeutic cancer vaccine provided clinical benefit to several patients with metastatic HER2-positive cancers who had not previously been treated with a HER2-targeted therapeutic, according ...
Sep 30, 2018
0
1
Deregulation and inhibition of the immune system contributes to cancer development. Many therapeutic strategies aim to re-stimulate the immune system to recognize cancer cells and target them for destruction. Researchers ...
Jan 3, 2017
0
28
A team led by Monash University and the University of Queensland has developed a new approach to harnessing the body's immune system to fight disease that could pave the way for a new class of cancer vaccine.
Jun 2, 2016
0
16
In a scientific discovery that has significant implications for preventing HIV infections, researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have identified a protein that could improve the body's ...
Jun 4, 2015
0
28
Celldex Therapeutics announced today that final data from its Phase 1 study of CDX-1401 in solid tumors, including long-term patient follow-up, have been published in Science Translational Medicine. The data demonstrate robust ...
Apr 16, 2014
1
0
